showed a trendP = 0.05
34%, P = 0.002), although the latter also showed a trend of increased mortality compared with Ubi-A10/+ controls (34 vs. 8%, P = 0.05).
34%, P = 0.002), although the latter also showed a trend of increased mortality compared with Ubi-A10/+ controls (34 vs. 8%, P = 0.05).